Corebridge Financial Inc. Sells 6,663 Shares of Docusign Inc. $DOCU

Corebridge Financial Inc. reduced its stake in Docusign Inc. (NASDAQ:DOCU) by 2.9% in the 1st quarter, HoldingsChannel reports. The firm owned 225,342 shares of the company’s stock after selling 6,663 shares during the quarter. Corebridge Financial Inc.’s holdings in Docusign were worth $18,343,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. American Century Companies Inc. increased its stake in Docusign by 3.1% in the first quarter. American Century Companies Inc. now owns 5,477,758 shares of the company’s stock valued at $445,890,000 after purchasing an additional 162,299 shares in the last quarter. Jericho Capital Asset Management L.P. increased its stake in Docusign by 34.0% in the fourth quarter. Jericho Capital Asset Management L.P. now owns 4,754,753 shares of the company’s stock valued at $427,642,000 after purchasing an additional 1,205,500 shares in the last quarter. Northern Trust Corp increased its stake in Docusign by 77.2% in the fourth quarter. Northern Trust Corp now owns 1,984,378 shares of the company’s stock valued at $178,475,000 after purchasing an additional 864,408 shares in the last quarter. Wellington Management Group LLP increased its stake in Docusign by 372.5% in the first quarter. Wellington Management Group LLP now owns 1,826,949 shares of the company’s stock valued at $148,714,000 after purchasing an additional 1,440,269 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in Docusign by 3.0% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,709,807 shares of the company’s stock valued at $153,780,000 after purchasing an additional 50,440 shares in the last quarter. 77.64% of the stock is owned by institutional investors.

Insider Activity

In related news, CEO Allan C. Thygesen sold 40,000 shares of the business’s stock in a transaction dated Tuesday, July 1st. The shares were sold at an average price of $77.51, for a total transaction of $3,100,400.00. Following the transaction, the chief executive officer directly owned 143,983 shares in the company, valued at approximately $11,160,122.33. The trade was a 21.74% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Blake Jeffrey Grayson sold 15,143 shares of the business’s stock in a transaction dated Wednesday, June 18th. The stock was sold at an average price of $74.80, for a total transaction of $1,132,696.40. Following the transaction, the chief financial officer owned 110,723 shares in the company, valued at approximately $8,282,080.40. This trade represents a 12.03% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 78,552 shares of company stock valued at $5,983,631 in the last three months. 1.01% of the stock is owned by company insiders.

Analyst Ratings Changes

DOCU has been the subject of several research analyst reports. Wall Street Zen downgraded shares of Docusign from a “buy” rating to a “hold” rating in a research note on Saturday, August 2nd. JPMorgan Chase & Co. decreased their target price on shares of Docusign from $81.00 to $77.00 and set a “neutral” rating for the company in a research report on Friday, June 6th. UBS Group decreased their target price on shares of Docusign from $85.00 to $80.00 and set a “neutral” rating for the company in a research report on Friday, June 6th. Wells Fargo & Company raised shares of Docusign from an “underweight” rating to an “equal weight” rating and boosted their target price for the stock from $67.00 to $80.00 in a research report on Friday, June 13th. Finally, Wedbush decreased their target price on shares of Docusign from $100.00 to $85.00 and set a “neutral” rating for the company in a research report on Thursday, June 12th. Four research analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $89.77.

Docusign Stock Performance

Docusign stock opened at $73.94 on Tuesday. Docusign Inc. has a fifty-two week low of $54.31 and a fifty-two week high of $107.86. The stock has a market cap of $14.94 billion, a PE ratio of 13.98, a price-to-earnings-growth ratio of 27.92 and a beta of 1.01. The firm’s 50-day simple moving average is $75.43 and its 200 day simple moving average is $80.06.

Docusign (NASDAQ:DOCU) last released its quarterly earnings results on Thursday, June 5th. The company reported $0.90 earnings per share for the quarter, topping the consensus estimate of $0.81 by $0.09. Docusign had a net margin of 36.50% and a return on equity of 14.27%. The business had revenue of $763.65 million for the quarter, compared to analysts’ expectations of $748.79 million. During the same period in the previous year, the company earned $0.82 earnings per share. The firm’s revenue for the quarter was up 7.6% compared to the same quarter last year. Docusign has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. As a group, analysts predict that Docusign Inc. will post 1.17 EPS for the current fiscal year.

Docusign declared that its board has authorized a stock repurchase program on Thursday, June 5th that permits the company to buyback $1.00 billion in outstanding shares. This buyback authorization permits the company to purchase up to 6.6% of its stock through open market purchases. Stock buyback programs are usually an indication that the company’s board believes its shares are undervalued.

Docusign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.